<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="51910">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02430402</url>
  </required_header>
  <id_info>
    <org_study_id>013.5</org_study_id>
    <nct_id>NCT02430402</nct_id>
  </id_info>
  <brief_title>Rehabilitation of Young Patients With Rheumatic Diseases in a Warm Climate</brief_title>
  <official_title>Effect of Rehabilitation of Young Patients With Rheumatic Diseases in a Warm Climate. A Pilot Randomised Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Norwegian University of Science and Technology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>St. Olavs Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Norwegian University of Science and Technology</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Young patients with rheumatic diseases have challenges different from older patients due to
      their life situation. It has been reported that they do not have the same benefit from age
      non-specific rehabilitation in warm climate. This trial will test the effect of a specially
      adapted version of a rehabilitation program delivered in Spain (warm climate) for Norwegian
      young adults aged 20-25 years.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2015</start_date>
  <completion_date type="Anticipated">August 2017</completion_date>
  <primary_completion_date type="Anticipated">August 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Coping (Effective Consumer Scale (EC17) and Patient Activation Measure (PAM)</measure>
    <time_frame>12 months</time_frame>
    <description>Measured with Effective Consumer Scale (EC17) and Patient Activation Measure (PAM)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>30 second sit to stand test</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>EQ5D</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Numerical Rating Scales (NRS) fatigue question</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hannover functional Scale</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Coop Wonca</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hopkins Symptom Checklist</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Specific Functional scale</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Numerical Rating Scales (NRS) pain question</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Rheumatic Diseases</condition>
  <arm_group>
    <arm_group_label>Climate therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Climate therapy consisting of 3 week stay at rehabilitation facility in Spain</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Usual care provided as needed / agreed between patient and health care providers</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Rehabilitation in warm climate</intervention_name>
    <arm_group_label>Climate therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Inflammatory rheumatic disease

          -  Self reliant in daily life

        Exclusion Criteria:

        - conditions that might influence ability to fly to Spain and participate in
        rehabilitation in warm climate (Unstable heart disease, Serious lung disease, Chronic open
        ulcers, Serious mental health conditions, alcohol or drug addiction, Intolerant of sun and
        heat)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Aslak Steinsbekk, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Norwegian University of Science and Technology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Aslak Steinsbekk, PhD</last_name>
    <phone>+4741559076</phone>
    <email>aslak.steinsbekk@ntnu.no</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ingrid Rekaa Nilsen</last_name>
    <phone>+47 47663721</phone>
    <email>Ingrid.Rekaa.Nilssen@stolav.no</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Institute for Social Medicine</name>
      <address>
        <city>Trondheim</city>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aslak Steinsbekk, PhD</last_name>
      <email>aslak.steinsbekk@ntnu.no</email>
    </contact>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <lastchanged_date>November 8, 2016</lastchanged_date>
  <firstreceived_date>April 22, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Climatotherapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Rheumatic Diseases</mesh_term>
    <mesh_term>Collagen Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
